The cardiac effects of calcium channel blockers (CCBs) related to cardiac remodeling are inconsistent. Matrix metalloproteinases (MMPs) contribute to tissue remodeling. Cardiac fibroblasts play an important role in the regulation of collagen degradation by MMPs. Using gelatin zymography, Western blotting, Griess reagent, and a calcium kit-fluo 3, we investigated the effects of nifedipine, verapamil, diltiazem, and amlodipine on MMP-2 expression and further elucidate the mechanisms in cultured rat cardiac fibroblasts. Nifedipine increased and amlodipine decreased the expression of MMP-2; however, neither verapamil nor diltiazem altered MMP-2 expression. Nifedipine also increased nitrite production, and this increase was blunted by a nitric oxide (NO) synthases inhibitor (L-NAME). Nifedipine-induced MMP-2 expression was also blunted by L-NAME. An NO donor (sodium nitroprusside) induced MMP-2 expression. Data indicated that nifedipine might increase MMP-2 expression through a possible NO-dependent pathway. Amlodipine had no influence on nitrite production. The amlodipine-induced decrease of MMP-2 expression was abolished by two protein tyrosine kinase inhibitors, genistein and herbimycin A, indicating that amlodipine might decrease MMP-2 expression through a possible protein tyrosine kinase pathway. None of the four CCBs could alter the fluoscence intensity of fluo 3, indicating that the effects of CCBs on MMP-2 expression were independent of the variation in intracellular Ca 2+ concentration. Our findings revealed that different CCBs exerted different effects on MMP-2 expression in cardiac fibroblasts.
M yocardial extracellular matrix remodeling has been proposed to participate in the development of ventricular dilatation and heart failure. The extracellular matrix of the heart includes a fibrillar collagen network, a basement membrane, and proteoglycans. 1 The matrix metalloproteinases (MMPs) are a family of zinc-dependent enzymes demonstrated to contribute to tissue remodeling in a number of disease states.
2 MMP-2 is one of the MMPs that may have particular relevance to myocardial remodeling. 1 The potent gelatinase, MMP-2, can also cleave fibrillar collagen 3 in addition to the basement membrane. 4 Increased MMP-2 activity in heart failure has been identified in humans. 5 MMP activity contributed to left ventricular dilation and progression to left ventricular dysfunction in a rodent heart failure model, and direct MMP inhibition can attenuate this process. 6 Calcium channel blockers (CCBs) are potent vasodilators widely used in the treatment of hypertension and angina pectoris. However, unwanted cardiac performance of CCBs has been reported and is thought to act via negative inotropic effects and neurohormonal activation. 7 The adverse effects of CCBs may be attributable to direct cardiodepressant action of these drugs on an already dysfunctioning myocardium. 7 Recently, CCBs have been shown to limit cardiac remodeling and improve cardiac function in myocardial infarction-induced heart failure in rats. 8 On the other hand, biphasic survival response to amlodipine after myocardial infarction in rats has been recently reported to be associated with cardiac vascular remodeling. 9 These results prompted us to examine the effects of the CCBs on processes related to cardiac remodeling. Nearly all CCBs used clinically act on the L-type calcium channels and belong to 3 distinct classes of compounds, including dihydropyridines (eg, nifedipine, amlodipine), benzothiazepines (eg, diltiazem), and phenylalkylamines (eg, verapamil). 10 Therefore, we selected nifedipine, diltiazem, verapamil, and amlodipine as CCB representatives.
Fibroblasts are the most abundant cell type in the heart and play a major role in synthesizing components of the cardiac extracellular matrix. 11 Cardiac fibroblasts have also been shown to play an important role in the regulation of collagen degradation by MMPs. 12 Therefore, the present study was designed to study whether CCBs affect MMP-2 expression in cardiac fibroblasts.
METHODS

Materials
The chemicals used in this study were obtained from the following sources: Dulbecco modified Eagle medium (DMEM) was obtained from GIBCO (Grand Island, NY); nifedipine was kindly supplied by Bayer Japan (Osaka, Japan). Amlodipine was obtained from Sumitomo Pharmaceuticals (Osaka, Japan). N G -nitro-L-arginine methyl ester (L-NAME) was purchased from Sigma Chemical Co. (St. Louis, MO). Sodium nitroprusside (SNP) was obtained from ICN Biomedical Inc. (Aurora, OH). Mouse monoclonal Anti-MMP-2 antibody was obtained from Fuji Chemical Industries (Toyama, Japan). Genistein and herbimycin A were purchased from Wako (Osaka, Japan). Calcium Kit-Fluo 3 was obtained from Dojindo Laboratories (Tokyo, Japan). All other chemicals were of reagent grade or were the highest grade commercially available.
Cell Culture
The animal protocols used in this experiment were reviewed by the Institutional Animal Care and Use Committee at Fukui University. Primary cultures of neonatal rat cardiac fibroblasts were prepared as previously described with some modifications. 13 Briefly, hearts were removed from 1-to 2-day-old Wistar rats anesthetized by ether under aseptic conditions and placed in Ca 2+ and Mg 2+ free phosphate-buffered saline (PBS). The hearts were washed with PBS, and the atria and aorta were discarded. The ventricles were minced with scissors into 1-to 3-mm 3 fragments, and they were then enzymatically digested 4 times for 10 to 15 minutes each with 10 mL of PBS containing 0.07% trypsin. The liberated cells were collected by centrifugation at 1000 × g for 5 minutes and incubated in 100-mm glass culture dishes for 60 minutes at 37°C in a humidified incubator with 5% CO 2 -95% air. During this time, the majority of myocardiocytes remained in suspension, whereas the nonmyocardiocytes attached more readily to the dish. Subsequently, the medium containing the myocardiocytes was aspirated and discarded. Highly enriched cultures of cardiac nonmyocytes were prepared by 2 passages of the cells adherent to the culture dish during the replating procedure. 14 Until the second passage, cells were maintained in DMEM supplemented with 10% fetal calf serum. The nature of cells was determined by immunofluorescence staining with antivimentin for identification of fibroblasts, and more than 95% of the cells were stained positively. Cardiac fibroblast cultures between passages 3 and 4 were used in this study. To determine whether signal transduction pathways were modified during cell culture, acute isolate fibroblasts were also used.
Gelatin Zymography
Cardiac fibroblasts were plated in 6-well plates (5 × 10 4 cells/well), incubated at 37°C in a humidified atmosphere of 95% air-5% CO 2 , and maintained in DMEM with 10% fetal calf serum until subconfluent. The subconfluent cells were serum deprived and treated with CCBs (nifedipine, verapamil, diltiazem, and amlodipine between concentrations of 10 −9 M to 10 −6 M), SNP, or in combination with L-NAME for 24 hours. After treatment, media were harvested, centrifuged at 2000 × g for 10 minutes and normalized for cell protein content using a Bio-Rad assay. Samples of 20 µg protein were applied without reduction to a 7.5% polyacrylamide slab gel impregnated with 1 mg/ml gelatin. 15 After electrophoresis, the gel was washed at room temperature for 30 minutes in washing buffer (50 mM Tris-Cl, pH 7.5, 15 mM CaCl 2 , 1 µM ZnCl 2 , and 2.5% Triton X-100), then incubated overnight at 37°C with shaking in the same buffer but containing 1% rather than 2.5% Triton X-100. The gel was stained with a solution of 0.1% Coomassie brilliant blue R-250. Clear zones against the blue background indicated the presence of gelatinase. To quantify the amount of gelatinase production, the stained zymograms were scanned on a densitograph (ATTO, Tokyo, Japan) as described previously. 16 A protein marker and control MMPs (Sigma-Aldrich, St. Louis, MO) were electrophoresed in parallel for molecular weight identification.
Western Blotting
After various treatments for 24 hours, medium samples were harvested with the protease inhibitors phenylmethane sulfonyl fluoride (0.1 mM) and leupeptin (10 µg/ml), centrifuged at 2000 × g for 10 minutes, protein concentration was measured and separated by electrophoresis on 7.5% sodium dodecyl sulfate (SDS) polyacrylamide gels followed by transfer onto polyvinylidene diflouride membranes (Immobilon P, Millipore, 0.22 µm pore size). The membranes were blocked in 5% skim milk in phosphate buffered saline containing 0.1% Tween 20 at room temperature for 1 hour, and probed with anti-human MMP-2 monoclonal antibody overnight. After washing 3 times with PBS containing 0.1% Tween 20, the membranes were incubated with secondary antibody conjugated with horseradish peroxidase for 1 hour as described previously, 17 and finally developed by ECL detection system (Amersham Pharmacia Biotech, Buckinghamshire, England).
Intracellular Calcium Variation
Intracellular calcium variations were evaluated with a Calcium Kit-Fluo 3, as previously described 18 and the procedure provided by Dojindo Laboratories (Tokyo, Japan). Briefly, cardiac fibroblasts were seeded in 96-well microplates at 1.5 × 10 4 cells/well and cultured overnight. After treatments with various CCBs of different concentrations in extracellular calcium concentrations of 1.8 mM and 0 mM, the cells were loaded with loading buffer containing 6 µM fluo 3, 1.25 mM probenecid, and 0.04% pluronic F-127, incubated at 37°C for 1 hour. The cells were then continuously bathed in recording buffer containing no indicator. The wavelength of emission for analysis was 538 nm and of excitation was 485 nm. Changes in the fluoscence intensity of fluo 3 in the cells that indicated the variation of intracellular calcium were recorded with a Fluoroskan Ascent (Labsystems, Helsinki, Finland).
Nitrite Production
Nitrite production, an indicator of nitric oxide (NO) synthesis, was measured by adding of 100 µL of Griess reagent (1% sulfanilamide and 0.1% naphthylethylenediamide in 5% phosphoric acid) to 100 µL samples of cell culture medium. 19 The optical density at 540 nm (OD 540 ) was measured using a Maxline Microplate Reader (Molecular Devices Corporation, Sunnyvale, CA). Nitrite concentrations were calculated by comparison with OD 540 of a standard solution of sodium nitrite prepared in culture medium. The amount of nitrite production was normalized for cell protein content using a Bio-Rad assay.
Statistical Analysis
Results were presented as percentages of the control and represent the means ± standard errors (SE) for 4 separate experiments performed in duplicate. Differences among all data were analyzed for significance by one-way analysis of variance (ANOVA) followed by unpaired Student t test. Differences of P < 0.05 were considered significant.
RESULTS
Effects of Calcium Channel Blockers on the Expression of MMP-2 in Cardiac Fibroblasts
Gelatin zymograms of cardiac fibroblasts-conditioned media showed that the major MMP expressed was MMP-2. Nifedipine increased and amlodipine decreased the gelatinolytic activity of MMP-2 significantly in a dose-dependent manner. However, neither verapamil nor diltiazem influenced the MMP-2 activity (Fig. 1A) . These effects were not toxic as determined by trypan blue exclusion.
Corresponding with the data of gelatin zymography, Western-blotting analysis demonstrated that nifedipine induced an increase, and amlodipine induced a decrease in MMP-2 expression dose dependently (Fig. 1B) .
Enzymatic activity of MMP-2 was inhibited after the addition of 10 mM EDTA, an inhibitor of MMPs, into the incubating buffer. In contrast, gelatinolytic bands displayed after zymography were unaffected by incubation in phenylmethylsulfonyl fluoride, an inhibitor of serine proteases (data not shown).
Effects of Calcium Channel Blockers on the Variation of Intracellular Calcium in Cardiac Fibroblasts
To ascertain how CCBs could interfere with intracellular calcium, changes in the fluoscence intensity of fluo 3 in the cardiac fibroblasts were recorded. None of the CCBs, nifedipine, verapamil, diltiazem, and amlodipine could significantly alter the fluoscence intensity of fluo 3 (Fig. 2) . When extracellular calcium was removed, there was approximately 43% less fluo 3 fluoscence intensity; however, none of the CCBs could alter the fluoscence intensity (Fig. 2) . Calcium 
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Calcium Channel Blockers and MMP-2 signal characteristics were not correlated with the number of passages in cell culture as confirmed by a study performed in acutely isolated fibroblasts (data not shown).
Effects of Calcium Channel Blockers on the Production of Nitrite in Cardiac Fibroblasts
To determine whether CCBs could alter NO synthesis, nitrite production of cardiac fibroblast-conditioned media were studied. The addition of nifedipine to cardiac fibroblasts in serum-free medium caused a significant increase in nitrite production in a dose-dependent manner, indicating that nifedipine increased NO synthesis. However, the other 3 CCBs studied (verapamil, diltiazem, and amlodipine) had no influence on nitrite production at any concentration (Fig. 3) .
To exclude the possibility that the nifedipine preparation contained lipopolysaccharide, several different preparations of nifedipine-with dimethyl sulfoxide, ethanol, and polyethylene glycol 400 (at 60°C) in the possible lowest concentration were compared. No differences were found in nitrite production of nifedipine prepared by any method (data not shown), indicating that the effect of nifedipine on nitrite production was inherent rather than from lipopolysaccharide contained in the preparation.
Effects of Sodium Nitroprusside on MMP-2 Expression in Cardiac Fibroblasts
To determine the effects of NO on gelatinase expression in cardiac fibroblast-conditioned media, we added an exogenous NO donor, SNP (ranging from 10 −7 M to 10 −3 M), to cardiac fibroblast cultures for 24 hours. SNP induced an increase on MMP-2 expression markedly and dose dependently (Fig. 4) .
Effects of L-NAME on Nitrite and MMP-2 Expression Induced by Nifedipine
To evaluate whether the effects of nifedipine on expression of MMP-2 were related to NO, subconfluent cardiac fibroblasts were treated with an NO synthase inhibitor-L-NAME for 30 minutes before treatment with nifedipine in culture media from concentrations of 10 −9 M to 10 −6 M for 24 hours. The pretreatment of L-NAME blunted both the increased nitrite and MMP-2 expression induced by nifedipine (Fig. 5A, B) , indicating a possibility that nifedipine affected MMP-2 expression via a pathway related to NO, at least in part.
Effects of Protein Tyrosine Kinase Inhibitors on Calcium Channel Blocker-Induced Alteration on MMP-2 Expression in Cardiac Fibroblasts
To evaluate whether the effects of amlodipine and nifedipine on expression of MMP-2 were related to protein tyrosine kinase, subconfluent cardiac fibroblasts were separately FIGURE 3. Effects of calcium channel blockers on nitrite production in cardiac fibroblasts. Nifedipine caused a significant increase in nitrite production in a dose-dependent manner as determined by Griess reagent. However, verapamil, diltiazem, and amlodipine did not influence nitrite production at any concentration. Data represent the mean ‫ע‬ standard error (SE) for 4 separate experiments performed in duplicate. *P < 0.05 versus control, ***P < 0.001 versus control. treated with 2 protein tyrosine kinase inhibitors, genistein and herbimycin A, for 10 minutes before treatment with amlodipine or nifedipine in culture media from concentrations of 10 −9 M to 10 −6 M for 24 hours. Both genistein (10 µM) and herbimycin A (0.5 µg/ml) abolished the decrease in MMP-2 expression induced by amlodipine (Fig. 6) ; however, neither genistein nor herbimycin A influenced the increase in MMP-2 expression induced by nifedipine (data not shown), indicating that amlodipine, but not nifedipine, might affect MMP-2 expression through a possible pathway related with a protein tyrosine kinase.
DISCUSSION
The present findings demonstrate for the first time that 2 CCBs, nifedipine and amlodipine, increase and decrease respectively the expression of MMP-2 through different possible related pathways, while neither verapamil nor diltiazem influenced MMP-2 expression in cardiac fibroblasts. Previous findings demonstrated that nifedipine and amlodipine had opposite effects on nitrite production in isolated hearts, 20 and may provide support to our investigation.
Although increased MMP-2 activity in heart failure has been identified in humans, 5 the dynamic process of ventricular remodeling with both above and below normal MMP activity and collagen concentration had been pointed out 21 and shown in transgenic mice with cardiac restricted overexpression of tumor necrosis factor that developed into progressive left ventricular remodeling. 22 Both potentially beneficial and potentially detrimental aspects of MMPs on myocardial injury and repair have been pointed out. 23 Furthermore, MMP-2 had been shown to degrade interleukin-1␤, 24 while inflammatory cytokines such as interleukin-1␤ exert a number of actions that may be important in myocardial remodeling and failure. 25 Therefore, although nifedipine increased MMP-2 expression differently than amlodipine, we cannot conclude whether or not the effects of nifedipine or amlodipine are beneficial. However, our data indicated that the various effects of CCBs on ventricular remodeling or heart failure might be related to the different effects of CCBs on MMP-2 expression in cardiac fibroblasts, at least in part. How and when to use the different CCBs beneficially according to their different characters on MMP-2 is important and needs to be examined in future studies.
The maximum concentration of nifedipine (10 −6 M) used in our study was higher than clinical plasma concentrations reported (about 0.2 µM). 26 It had been shown that nifedipine may accumulate in membranous structures, resulting in higher localized concentrations of the compound. 27 Furthermore, it has been accepted that high in vitro concentrations of CCBs are required to achieve pharmacological effects, and such concentrations have been used by others. 28 Therefore, all maximum CCB concentrations used in the present study were selected as 10 −6 M, and no cytotoxic effects were found as detected by trypan blue. Columns indicate data of gelatinolytic activity as percentages of the amount of control, and represent the means ‫ע‬ standard error (SE) for 4 separate experiments performed in duplicate. **P < 0.01 versus control, ***P < 0.001 versus control.
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Calcium Channel Blockers and MMP-2
Pathways to oscillate intracellular calcium are comprised mainly of: (1) various calcium channels in cell membrane (receptor-mediated calcium channels, voltage-dependent calcium channels, non-specific cation channels); (2) Na + -Ca 2+ exchange; (3) release of intracellular calcium store. 29 Cardiac fibroblasts have been shown to release calcium from intracellular stores 30, 31 and from extracellular calcium influx. 31, 32 In the present study, none of the CCBs, nifedipine, verapamil, diltiazem, or amlodipine, could significantly alter the fluoscence intensity of fluo 3 in the presence or absence of extracellular calcium, indicating that the effects of CCBs on MMP-2 expression were independent of the variation in intracellular Ca 2+ concentration. A recent report that lacidipine, a third-generation dihydropyridine calcium antagonist, inhibited MMP-9 secretion in human macrophages, independent of the variation in intracellular Ca 2+ concentration, 33 supports our present study. Therefore, there may be some other mechanisms for nifedipine and amlodipine to exert their effects on MMP-2 expression in cardiac fibroblasts independent of intracellular calcium variation.
NO is a free radical with an unpaired electron and is an important physiological messenger, produced by nitric oxide synthases that catalyze the reaction L-arginine to citrulline and NO. Evidence has accumulated that NO may mediate or contribute to the calcium channel-independent effects of CCBs. Ding and Vaziri 10 showed recently that nifedipine and diltiazem enhanced NO generation in cultured human coronary artery endothelial cells while no such effect was observed with verapamil. Because no L-type calcium channel has been observed in endothelial cells, 34 the CCBs must exert these effects via other mechanisms. Berkels et al 28 showed that the treatment of endothelial cells with nifedipine increased NO release due to an enhanced availability of NO by antioxidative protection. In the present study, nifedipine increased NO production in a dose-dependent manner, in the same degree with the studies mentioned above. 10, 28 There is much controversy as to the biologic activity of NO, whether it increases or decreases in left ventricular hypertrophy. 35 The diverse biologic actions of coronary endothelial NO during the progression of cardiac hypertrophy indicate that there is an increase in the basal activity of NO in early compensated left ventricular hypertrophy, followed by a decrease in both endothelial NO synthase expression and NO bioactivity during the transition to myocardial failure. 35 Whether and when the increase or decrease of NO is beneficial is a subject beyond the present study, but the present study emphasizes that, at least in cardiac fibroblasts, CCBs might affect NO production differently to mediate their intracellular calcium-independent effects, at least in part.
Nitric oxide is recognized as an important signal molecule between and within cells. 36 Recent studies suggest that a complex relationship exists between NO and MMPs in cultured fibroblasts. Findings that increased NO generation by an NO donor, SNAP, stimulated the production of 72 kDa MMP-2 in rheumatoid synovial fibroblasts suggest that NO may play a critical role in regulating articular extracellular matrix remodeling in rheumatoid arthritis through the production of MMP-2. 37 Others investigated the presence of NOmediated augmented regulation of MMP-1 production in cultured human uterine cervical fibroblasts. 38 In the present study, L-NAME, an NO synthase inhibitor, significantly blocked the inducing effect of nifedipine on MMP-2 in rat cardiac fibroblasts, and SNP increased MMP-2 expression. These results suggest that the alteration in expression of MMP-2 induced by nifedipine might be related, at least in part, to NO.
As opposed to nifedipine, which increased both MMP-2 and nitrite expression, amlodipine decreased MMP-2 expression but had no influence on nitrite production; therefore, there must be another signal pathway mediating the decreasing effect of amlodipine on MMP-2 expression in rat cardiac fibroblasts. Protein phosphorylation on tyrosine residues by protein tyrosine kinases is an important regulator of cell function. 39 Li et al 40 and our laboratory 41 have demonstrated that MMP-2 production or activation was induced through protein tyrosine phosphorylation. Therefore, it is plausible to assume that a protein tyrosine kinase pathway may play a role in the decreasing effect of amlodipine on production of MMP-2 in cardiac fibroblasts. In the present study, we observed that the amlodipineinduced decrease in MMP-2 expression was abolished by either genistein or herbimycin A, both protein tyrosine kinase inhibitors. Therefore, our data indicated that the effects of amlodipine on expression of MMP-2 in rat cardiac fibroblasts might be mediated via a protein tyrosine kinase related pathway. The different roles of tyrosine kinases in the present study and our previous study 41 might be attributable to the different cell types used-cardiac fibroblasts and vascular smooth muscle cells.
CONCLUSION
It is of interest to note that we found, at least for cardiac fibroblasts, that the same dihydropyridine group L-type CCBs, nifedipine and amlodipine, act differently on MMP-2 expression (increase and decrease, respectively), and may be mediated independently via different pathways-NO and protein tyrosine kinase related pathways, but not the variations of intracellular calcium concentration. Verapamil and diltiazem, however, did not influence MMP-2 expression. Our findings revealed that different CCBs exerted different effects on MMP-2 expression in cardiac fibroblasts.
